ResourceDrug Discovery & Development
Selecting the location of a phase I clinical trial site for EU registration
9 Jan 2023In this white paper, QPS provides insight into conducting trials that will support registration of a medicinal product in the EU. In such cases, regional authorities establish trial requirements as set forth in the marketing authorization application (MAA).
Related Products
Request Quote for All Products
QPS Clinical Phase I/IIa Development Services
QPSMoving quickly and safely through Phase I/IIa trials is critical to successful drug development. The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually.